FDA Inspection
Intrathecal Compounding Specialists, LLCIntrathecal Compounding Specialists, LLC – FDA Inspection, Nov 17, 2017
Record Details
This FDA Inspection record concerns Intrathecal Compounding Specialists, LLC, with an inspection on November 17, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · dad66aba-d8dd-4713-acd3-0ef6a8010f19
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1034828
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- 483 Response
FDA Citations
10- FDCA 501(a)(2)(A)Disinfectant contact time
- FDCA 501(a)(2)(A)Disinfecting materials, aseptic processing area
- FDCA 501(a)(2)(A)Non-microbial contamination, production area
- FDCA 501(a)(2)(A)Improper gowning, contamination
- FDCA 501(a)(2)(A)Personnel in aseptic processing, cleanroom gowning
- FDCA 501(a)(2)(A)Exposure of personnel in aspectic processing
- FDCA 501(a)(2)(A)Personnel contact outside ISO 5 area
- FDCA 501(a)(2)(A)Cleanliness, ISO-classified areas
- FDCA 501(a)(2)(A)Actionable microbial contamination, ISO 5 area
- FDCA 501(a)(2)(A)Highly potent drugs, prevention of cross-contamination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Intrathecal Compounding Specialists, LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 19, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 14, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Intrathecal Compounding Specialists, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.